Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Whitley M. Yi"'
Autor:
Whitley M. Yi, Kelly E. Schoeppler, Jaclyn Jaeger, Scott W. Mueller, Robert MacLaren, Douglas N. Fish, Tyree H. Kiser
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 16, Iss 1, Pp 1-14 (2017)
Abstract Background Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are li
Externí odkaz:
https://doaj.org/article/e30344579ca149a49c0e111866248e61
Publikováno v:
Hosp Pharm
Purpose: The purpose of this article is to offer key recommendations based on the authors’ experiences for utilizing pharmacy analytics to support moving beyond standard-of-practice operational metrics towards high impact reporting to drive day-to-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c7ab67c01864b4eadceec94e753e37
https://pubmed.ncbi.nlm.nih.gov/34720151
https://pubmed.ncbi.nlm.nih.gov/34720151
Autor:
Whitley M Yi, Trinh Le, Andrew J McLaughlin, Scott D. Nelson, C D R Kendra Worthy Woodbury, Bruce W. Chaffee, Asha L Kalichira, Hardik Patel, Katherine A Miller, Casey A Olsen, Nick Schutz, Andrew H. Smith
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 77(23)
Pharmacists are responsible for determining which aspects of medication use and management are best handled by pharmacists, by artificial intelligence (AI), or by pharmacists who receive advice from AI-based systems. Pharmacists should use scientific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a2421aa5f584ff81243e2a83044603b
https://pubmed.ncbi.nlm.nih.gov/32918073
https://pubmed.ncbi.nlm.nih.gov/32918073
Autor:
H. Mindy Lam, Miranda E. Kroehl, Jaclyn Jaeger, Whitley M. Yi, Danielle F. Loeb, Katy E. Trinkley, Shubha Bhat, Angela M. Thompson
Objective Clinical pharmacists use population health methods to generate chronic disease management referrals for patients with uncontrolled chronic conditions. The purpose of this study was to compare primary care providers’ (PCPs) referral respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e015542270ea19774ada7bbe213981
https://europepmc.org/articles/PMC6756144/
https://europepmc.org/articles/PMC6756144/
Autor:
Toyin Tofade, Lina Bader, Claire Anderson, Andreia Bruno, Ian Larson, Tina Penick Brock, Ema Paulino, Susan James, Kirsten Galbraith, Jill Boone, Ian Bates, Michael J. Rouse, Joana Carrasqueira, Whitley M. Yi
Publikováno v:
Innov Pharm
INNOVATIONS in Pharmacy, Vol 9, Iss 3 (2018)
INNOVATIONS in Pharmacy, Vol 9, Iss 3 (2018)
In November 2016, the International Pharmaceutical Federation (FIP) endeavored to create an environment to foster a shared vision to lead a transformative pharmaceutical workforce roadmap. Three milestone documents were developed and presented at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d708a08e6a91d1722dd45e82c535d34
https://europepmc.org/articles/PMC6302750/
https://europepmc.org/articles/PMC6302750/
Autor:
Robert MacLaren, Scott W. Mueller, Tyree H. Kiser, Whitley M. Yi, Douglas N. Fish, Kelly E. Schoeppler, Jaclyn Jaeger
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials
Annals of Clinical Microbiology and Antimicrobials, Vol 16, Iss 1, Pp 1-14 (2017)
Annals of Clinical Microbiology and Antimicrobials, Vol 16, Iss 1, Pp 1-14 (2017)
Background Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are limited for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ee6e8b8e613a449fcb095e9882f56e
https://doi.org/10.1186/s12941-017-0235-8
https://doi.org/10.1186/s12941-017-0235-8